Hemostasis during normal pregnancy and puerperlum

Seminars in Thrombosis and Hemostasis

Volumn 29, Issue 2, 2003, Pages 125-130

  Hellgren, Margareta ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Clotting factors; Fibrinolysis; Hemostasis; Inhibitors; Platelets; Pregnancy

Indexed keywords

ACTIVATED PROTEIN C; ACUTE PHASE PROTEIN; ALPHA 2 ANTIPLASMIN; BETA THROMBOGLOBULIN; BIOCHEMICAL MARKER; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING INHIBITOR; D DIMER; FIBRIN; FIBRINOGEN; FIBRINOPEPTIDE A; KALLIKREIN INHIBITOR; PLASMIN ANTIPLASMIN COMPLEX; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEIN S; PROTHROMBIN COMPLEX; PROTHROMBIN FRAGMENT 1; PROTHROMBIN FRAGMENT 2; THROMBIN; THROMBIN ACTIVATED FIBRINOLYSIS INHIBITOR; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE FACTOR 4; THROMBOMODULIN; THROMBOPLASTIN; UNCLASSIFIED DRUG; UROKINASE;

ACTIVATED PROTEIN C RESISTANCE; ACUTE PHASE RESPONSE; BLEEDING; BLEEDING TIME; BLOOD CLOTTING; CHILDBIRTH; DELIVERY; DIAGNOSTIC TEST; FEMALE; FIBRINOLYSIS; GESTATIONAL THROMBOCYTOPENIA; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; LACTATION; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PRIORITY JOURNAL; PROTHROMBIN TIME; PUERPERIUM; REVIEW; THIRD TRIMESTER PREGNANCY; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; THROMBOELASTOGRAPHY; UTERUS CONTRACTION;

BIOLOGICAL MARKERS; BLOOD COAGULATION TESTS; FEMALE; HEMOSTASIS; HUMANS; PLATELET FUNCTION TESTS; POSTPARTUM PERIOD; PREGNANCY; THROMBOPHILIA;

EID: 0037393051     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38897     Document Type: Review

References (43)

1. Sheppard BL, Bonnar J. Uteroplacental hemostasis in intra-uterine fetal growth retardation. Semin Thromb Hemost 1999;25:443-446
2. Hett DA, Walker D, Pilkington SN, Smith DC. Sonoclot analysis. Br J Anaesthesiol 1995;75:771-776
3. Kjellberg U, Hellgren M. Sonoclot signature during normal pregnancy. Intensive Care Med 2000;26:206-211
4. Chandler WL. The thromboelastograph and the thromboelastograph technique. Semin Thromb Hemost 1995;21:1-6
5. Sharma SK, Philip J. The effect of anesthetic techniques on blood coagulability in parturients as measured by thromboelastography. Anesth Analg 1997;85:82-86
6. Sharma SK, Philip J, Whitten CW, et al. Assessment of changes in coagulation in parturients with preeclampsia using thrombelastography. Anesthesiology 1999;90:385-390
7. He S, Bremme K, Blombäck M. A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results. Thromb Res 1999;96:145-156
8. Hemker HC, Beguin S. Thrombin generation in plasma: its assessment via endogenous thrombin potential. Thromb Haemost 1995;74:134-138
9. Nicolaes GA, Thomassen MC, Tans G, et al. Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC resistant individuals. Blood Coagul Fibrinolysis 1997;8:28-38
10. Eichinger S, Weltermann A, Philipp K, et al. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost 1999;82:1232-1236
11. Clark P, Brennand J, Conkie JA, et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998;79:1166-1170
12. Cerneca F, Ricci G, Simeone R, et al. Coagulation and fibrinolysis changes in normal pregnancy, increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 1997;73:31-36
13. Berge LN, Lyngmo V, Svensson B, Nordoy A. The bleeding time in women: an influence of the sex hormones. Acta Obstet Gynecol Scand 1993;72 423-427
14. Rymark P, Berntorp E, Nordsjö P, et al. Low-dose aspirin to pregnant women: single dose pharmacokinetics and influence of short-term treatment on bleeding time. J Perinat Med 1994;22:205-211
15. Rakoczi I, Tallian F, Bagdany S, Gati I. Platelet life-span in normal pregnancy and preeclampsia as determined by a non-radioisotope technique. Thromb Res 1979;15:553-556
16. Pekonen F, Rasi V, Ämmälä M, et al. Platelet function in normal and preeclamptic pregnancy. Thromb Res 1986;43:553-560
17. Gatti L, Tenconi PM, Guarneri D, et al. Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy. Int J Clin Lab Res 1994;24:217-219
18. Howarth S, Marshall LR, Barr AL, et al. Platelet indices during normal pregnancy and preeclampsia. Br J Biomed Sci 1999;56:20-22
19. Hayashi M, Kuimi F, Mitsuya K. Changes in platelet ATP secretion and aggregation during pregnancy and in preeclampsia. Am J Med Sci 1999;318:115-121
20. Aster RH. Gestational thrombocytopenia. A plea for conservative management. N Engl J Med 1990;323:264-266
21. Burrows RF, Kelton JG. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. Am J Obstet Gynecol 1990;162:731-734
22. Louden KA, Broughton Pipkin F, Heptinstall S, et al. A longitudinal study of platelet behaviour and thromboxane production in whole blood in normal pregnancy and the puerperium. Br J Obstet Gynecol 1990;97:1108-1114
23. Nicolini U, Guarneri D, Gianotti GA, et al. Maternal and fetal platelet activation in normal pregnancy. Obstet Gynecol 1994;83:65-69
24. Konijnenberg A, Stokkers EW, van der Post JAM, et al. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules. Am J Obstet Gynecol 1997;176:461-469
25. Star J, Rosene K, Ferland J, et al. Flow cytometric analysis of platelet activation throughout normal gestation. Obstet Gynecol 1997;90:562-568
26. Douglas JT, Shah M, Lowe GD, et al. Plasma fibrinopeptide A and beta-thromboglobulin in preeclampsia and pregnancy hypertension. Thromb Haemost 1982;1:54-55
27. Romero R, Snyder E, Scott D, et al. Beta-thromboglobulin during normal pregnancy, labour and puerperium. Am J Perinatol 1988;5:109-112
28. Ayhan A, Akkok E, Urman B, et al. Beta-thromboglobulin and platelet factor 4 levels in pregnancy and preeclampsia. Gynecol Obstet Invest 1990;30:12-14
29. Hellgren M, Blombäck M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. Gynecol Obstet Invest 1981;12:141-154
30. Kjellberg U, Andersson N-E, Rosén S, et al. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999;81:527-531
31. Sattar N, Greer IA, Rumley A, et al. A longitudinal study of the relationships between haemostatic, lipid and oestradiol changes during normal human pregnancy. Thromb Haemost 1999;81:71-75
32. Bellart J, Gilabert R, Fontcuberta J, et al. Coagulation and fibrinolysis in normal pregnancy and in gestational diabetes. Am J Perinatol 1998;15:479-486
33. Bremme K, Östlund E, Almquist I, et al. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol 1992;80:132-137
34. She H, Wramsby M, Bokarewa M, et al. Decrease in protein C inhibitor activity and acquired APC resistance during normal pregnancy. J Thromb Thrombolysis 2000;9:277-281
35. Sandset PM, Hellgren M, Uvebrandt M, Bergström H. Extrinsic coagulation pathway inhibitor and heparin co-factor II during normal and hypertensive pregnancy. Thromb Res 1989;55:665-670
36. de Moerloose P, Mermillod N, Amiral J, Reber G. Thrombomodulin levels during normal pregnancy, at delivery and the postpartum: comparison with tissue-type activator and plasminogen activator inhibitor-1. Thromb Haemost 1998;79:554-556
37. Nakashima A, Kobayashi T, Terao T. Fibrinolysis during normal pregnancy and severe preeclampsia; relationships between plasma levels of plasminogen activators and inhibitors. Gynecol Obstet Invest 1996;42:95-101
38. Bellart J, Gilabert R, Fontcuberta J, et al. Fibrinolysis changes in normal pregnancy. J Perinat Med 1997;25:368-372
39. Chetaille P, Alessi MC, Kouassi D, et al. Plasma TAFI antigen variations in healthy subjects. Thromb Haemost 2000;83:902-905
40. Bellart J, Gilabert R, Miralles RM, et al. Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy. Gynecol Obstet Invest 1998;46:17-21
41. Andersson T, Lorentzen B, Högdahl H, et al. Thrombin-inhibitor complexes in the blood during and after delivery. Thromb Res 1996;82:109-117
42. Montes R, Paramo JA, Angles-Cano E, Rocha E. Development and clinical application of a new ELISA assay to determine plasmin-alfa-antiplasmin complexes in plasma. Br J Haematol 1996;92:979-985
43. Dahlman T, Hellgren M, Blombäck M. Changes in blood coagulation and fibrinolysis in the normal puerperium. Gynecol Obstet Invest 1985;20:37-44